These free D.Pharm (Diploma in Pharmacy) notes on haematological disorders iron deficiency and megaloblastic anaemia are part of Pharmacotherapeutics, Part II (2nd year). Below is a short summary of what the notes cover. For the full explanation, read the complete PDF notes embedded at the end of the page. You can browse every topic in the Pharmacotherapeutics category.
Table of Contents
Overview of haematological disorders iron deficiency and megaloblastic anaemia
These notes cover haematological disorders with a focus on iron deficiency anaemia and megaloblastic anaemia. For each, they explain the causes, pathogenesis, clinical features, and the non-pharmacological and pharmacological management, including diet, iron therapy, vitamin B12 and folic acid.
Introduction
Haematological (blood) diseases are illnesses that affect the platelets, red blood cells, white blood cells, bone marrow, lymph nodes and spleen. Many of them can affect children.
Iron Deficiency Anaemia
Iron deficiency anaemia (IDA) is very common, especially in women. Anaemia means that the blood does not have enough healthy RBCs (red blood cells) to carry oxygen to the body tissues.
Topics covered: Etiology of Iron Deficiency Anaemia; Pathogenesis of Iron Deficiency Anaemia; Non-pharmacological Management of Iron Deficiency Anaemia; Pharmacological Management of Iron Deficiency Anaemia.
Megaloblastic Anaemia
Megaloblastic anaemia is a condition in which the bone marrow forms large, abnormal and immature RBCs called megaloblasts. Bone marrow is the soft, spongy material inside some bones.
Topics covered: Etiology of Megaloblastic Anaemia; Pathogenesis of Megaloblastic Anaemia; Vitamin B12 Deficiency Anaemia; Folic Acid (B9) Deficiency Anaemia; Non-pharmacological Management of Megaloblastic Anaemia.
Key points on haematological disorders iron deficiency and megaloblastic anaemia
- Iron deficiency anaemia occurs when lack of iron hinders haemoglobin production, causing tiredness and breathlessness, and is especially common in women.
- Main causes of iron deficiency anaemia are blood loss, poor diet, malabsorption such as celiac disease, pregnancy and endometriosis.
- Oral iron, often combined with ascorbic acid to improve absorption, is the preferred treatment, while parenteral iron is used for non-compliance or malabsorption.
- Megaloblastic anaemia is caused mainly by deficiency of vitamin B12 or folic acid, and the bone marrow forms large, immature red cells called megaloblasts.
- Pernicious anaemia, the severest vitamin B12 deficiency, results from lack of intrinsic factor; B12 deficiency is treated with monthly injections and folate deficiency with oral or intravenous folic acid.
Frequently asked questions on haematological disorders iron deficiency and megaloblastic anaemia
What are the causes of iron deficiency anaemia?
Causes include blood loss, internal bleeding, low iron in the diet, inability to absorb iron, pregnancy and endometriosis. Regular use of aspirin can also cause gastrointestinal bleeding.
What is megaloblastic anaemia?
It is a condition in which the bone marrow forms large, abnormal, immature red blood cells called megaloblasts. It is mainly due to deficiency of vitamin B12 or folic acid.
How is megaloblastic anaemia treated?
Vitamin B12 deficiency is treated with monthly vitamin B12 injections, and oral supplements are also an option. Folate deficiency is treated with oral or intravenous folic acid.
Download the Full PDF Notes: Haematological Disorders
This page gives a brief description of what the PDF covers. For more information, read the full embedded PDF notes below.
This page is part of the Pharmacotherapeutics series for D.Pharm students (Diploma in Pharmacy, not Pharm.D) on DPHARM GURU. Bookmark this page and share it with classmates who are preparing for the same exam.
Related notes: 9. MUSCULOSKELETAL DISORDERS, 10. DERMATOLOGY.
Next: 8. INFECTIOUS DISEASES. Back to the Pharmacotherapeutics category.


